<DOC>
	<DOCNO>NCT00575861</DOCNO>
	<brief_summary>Evaluate additive role zileuton 600mg qid clinically stable asthmatic Advair 250/50 bid . Since asthma endogenous inflammatory disease usually increase total exhaled , bronchial alveolar nitric oxide marker eosinophilic driven pathways inflammation . The addition zileuton leukotriene synthesis inhibitor together inhale corticosteroid reduce nitric oxide gas exchange .</brief_summary>
	<brief_title>Zileuton Exhaled Nitric Oxide Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Zileuton</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Nonsmoking Moderate severe persistent asthmatic Clinically stable X 6 week Advair 250/50 bid least 12 month No leukotriene synthesis inhibitor receptor antagonists 6 week</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>asthma</keyword>
	<keyword>nitric oxide gas exchange</keyword>
	<keyword>lung function</keyword>
</DOC>